Federal contract

Eli Lilly (LLY)VA awarded $4.5K

VA awarded Eli Lilly a contract with $4.5K committed so far.

$4.5K
committed so far
Signed
Aug 17, 2026
Updated
Sep 1, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 2, 2025CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  2. Jan 2, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  3. Mar 27, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  4. Jun 10, 2026Congress · 1 personMembers of Congress: 2 purchases
  5. Jul 1, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  6. Jul 10, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  7. Jul 13, 2026FDAFDA drug approval: Verzenio
  8. Jul 14, 2026FDAFDA drug approval: Retevmo
  9. Jul 14, 2026FDAFDA drug approval: Retevmo
  10. Jul 23, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.6%
  11. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
  12. Aug 7, 2026InsiderOfficer sold ~$5.95M of LLY shares in the open market
  13. Aug 10, 2026Insider · Their largest sale since 2014Officer sold ~$2.37M of LLY shares in the open market
  14. Aug 17, 2026 · this disclosureFederal contract · $5K obligatedDepartment of Veterans Affairs awarded Eli Lilly: $4.5K obligated to date

What came next

  1. Aug 17, 2026Insider · Their largest sale since 2022Officer sold ~$7.64M of LLY shares in the open market
  2. Aug 26, 2026FDAFDA drug approval: Zepbound
  3. Aug 27, 2026FDAFDA drug approval: Mounjaro
  4. Aug 27, 2026FDAFDA drug approval: Mounjaro
  5. Sep 18, 2026FDAFDA drug approval: Inluriyo
  6. Sep 18, 2026FDAFDA drug approval: Verzenio
  7. Sep 23, 2026FDAFDA drug approval: Onswik
  8. Sep 25, 2026FDAFDA drug approval: Olumiant
View the official recordUSAspending.gov award record

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for Eli Lilly

For Eli Lilly, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports, 189 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.

How this filing works

Other disclosures at Eli Lilly

Everything OQRO holds on this company is on its LLY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data